Drug Index

CYRAMZA

Generic: RAMUCIRUMAB

Review priority: STANDARD Marketing status: Prescription

Route: INJECTION
Class: General Medications
Safety profile: routine
Latest regulatory update: 19 Aug 2025, 12:00 am (UTC)

Structured Monograph

Approval overview CYRAMZA is listed in Drugs@FDA under application 125477 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient RAMUCIRUMAB Form and strength INJECTABLE;INJECTION - 100MG/10ML Sponsor ELI LILLY AND CO Submission history Latest submission status date: 2025-08-19 00:00:00. Submission type: SUPPL.